Two Chinese companies working directly under state supervision say they will be ready to mass produce a coronavirus vaccine by as early as December 2020.
VA researchers have enrolled 200 veterans in a trial testing whether the prostate cancer drug degarelix could prove to be an effective treatment for men with COVID-19.
The National Institutes of Health have launched a placebo-controlled trial testing the safety and efficacy of hydroxychloroquine and azithromycin as a treatment for COVID-19.
A new analysis suggests government funding for studies is shrinking, forcing researchers to turn to the pharmaceutical industry to support essential research.